Connect Biopharma Holdings (CNTB) Operating Leases (2020 - 2026)

Connect Biopharma Holdings (CNTB) has reported Operating Leases for 7 consecutive years, with $693000.0 the latest figure, recorded in Q1 2026.

• Quarterly Operating Leases fell 26.28% year-over-year to $693000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $693000.0 (down 26.28% YoY) and the FY2025 annual result came in at $368000.0, up 1433.33% from the prior year.
• Operating Leases advanced to $693000.0 in Q1 2026 per CNTB's latest filing, from $368000.0 in the prior quarter.
• Over the last five years, Operating Leases for CNTB reached as high as $940000.0 in Q1 2025 and fell as low as $24000.0 in Q4 2024.
• A 5-year average of $461689.9 and a median of $335000.0 in 2022 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2024 — Operating Leases plunged 86.67% — and 2025, when it soared 1433.33%.
• Year by year, Operating Leases stood at $239589.3 in 2022, then dropped by 24.87% to $180000.0 in 2023, then tumbled by 86.67% to $24000.0 in 2024, then surged by 1433.33% to $368000.0 in 2025, then surged by 88.32% to $693000.0 in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $693000.0, $368000.0, and $781000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.